Primary Cells Market size is expected to grow at a CAGR of 11.4% during the forecast period and the market size is expected to reach nearly USD 2.61 billion by 2029. The primary cells market is expected to grow in the forecast period owing to drive factors such as rapid growth in biotechnology and biopharmaceutical industries. Rapid growth in the biotechnology and biopharmaceutical industries, benefits of primary human cells over cell lines, partnerships, collaborations, and achievements are expected to drive the global primary cells market during the forecast period. Primary cells market report covers size, segments, and forecast by regions, top players, with past data along with the forecast period. The report covers an in-depth description, good scenario, wide product collections of key vendors and the business plan adopted by competitors along with their revenue, sales and Receptionist's five forces investigation.To know about the Research Methodology:-Request Free Sample Report Based on type, human primary cells segment held the dominant 11.4% market share in 2022. This global market has been developing at a higher speed with the development of imaginative frameworks and a developing end-client tendency. The human market reports deliver insight and expert analysis into key consumer trends and behavior in the marketplace. In addition to an overview of the key brands and market data. North America region is expected to hold a dominant position in the Global Market. The primary cell market in North America region is highly competitive the developed countries like the US and Canada have invested significantly in research and development (R&D) activities, which are expected to share significant growth in the regional market. These countries are initial adopters of knowledge in various verticals. The US and Canada are also the top countries in retail, financial services, banking, and other industries. Europe in holds the second promotion in terms of value. Healthcare remains a major area of focus for the Europe. Over the years, numerous policies have been launched to improve health care services in the region. Advanced economics in Europe present attractive growth opportunities for market players. In 2017, the gross domestic expenditure on R&D activities was more than Euro xx Bn as per the office for National Statistics. The objective of the report is to present a complete calculation of the Global Market and contains thoughtful insights, historical data, facts, industry-validated market data and plans with a suitable set of assumptions and methodology. The report also helps in the Global Market is a dynamic structure by identifying and analyzing the market segments and project the global market size. The additional, report also focuses on the competitive analysis of key player’s by-product, financial position, price, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment shortly to the emerging segment in the Global Market.
Primary Cells Market Scope: Inquire before buying
Primary Cells Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 1.22 Bn. Forecast Period 2023 to 2029 CAGR: 11.4% Market Size in 2029: US $ 2.61 Bn. Segments Covered: by Type Human Primary Cells Animal Primary Cells by Origin Hematopoietic Cells Skin Cells Gastrointestinal Cells Liver Cells Lung Cells Renal Cells Heart Cells Skeletal & Muscle Cells Other Primary Cells by End User Life Science Research Companies Research Institutes Primary Cells Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (razil, Argentina Rest of South America)Key Players:
1. Cell Biologics 2. ZenBio, 3. Axol Biosciences 4. Thermo Fisher Scientific, 5. Merck KGaA 6. Lonza 7. American Type Culture Collection 8. Promo cell 9. STEMCELL Technologies 10. ZenBio 11. KGaA 12. Duracell 13. Energizer 14. Hitachi Maxell 15. Sony 16. Toshiba 17. EXCELL Battery Group 18. Quallion 19. Panasonic 20. GP Batteries 21. Dongguan Large Electronics 22. HemaCare Corporation 23. AllCells Frequently Asked Questions: 1. Which region has the largest share in Global Primary Cells Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Primary Cells Market? Ans: The Global Primary Cells Market is growing at a CAGR of 11.4% during forecasting period 2023-2029. 3. What is scope of the Global Primary Cells market report? Ans: Global Primary Cells Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Primary Cells market? Ans: The important key players in the Global Primary Cells Market are – Cell Biologics, ZenBio,, Axol Biosciences, Thermo Fisher Scientific,, Merck KGaA, Lonza, American Type Culture Collection, Promo cell, STEMCELL Technologies, 5. What is the study period of this market? Ans: The Global Primary Cells Market is studied from 2022 to 2029.
Global Primary Cells Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Primary Cells Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Primary Cells Market Analysis and Forecast 6.1. Global Primary Cells Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Primary Cells Market Analysis and Forecast, by Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Primary Cells Market Value Share Analysis, by Type 7.4. Global Primary Cells Market Size (US$ Mn) Forecast, by Type 7.5. Global Primary Cells Market Analysis, by Type 7.6. Global Primary Cells Market Attractiveness Analysis, by Type 8. Global Primary Cells Market Analysis and Forecast, by Origin 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Primary Cells Market Value Share Analysis, by Origin 8.4. Global Primary Cells Market Size (US$ Mn) Forecast, by Origin 8.5. Global Primary Cells Market Analysis, by Origin 8.6. Global Primary Cells Market Attractiveness Analysis, by Origin 9. Global Primary Cells Market Analysis and Forecast, by End User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Primary Cells Market Value Share Analysis, by End User 9.4. Global Primary Cells Market Size (US$ Mn) Forecast, by End User 9.5. Global Primary Cells Market Analysis, by End User 9.6. Global Primary Cells Market Attractiveness Analysis, by End User 10. Global Primary Cells Market Analysis, by Region 10.1. Global Primary Cells Market Value Share Analysis, by Region 10.2. Global Primary Cells Market Size (US$ Mn) Forecast, by Region 10.3. Global Primary Cells Market Attractiveness Analysis, by Region 11. North America Primary Cell Market Analysis 11.1. Key Findings 11.2. North America Primary Cell Market Overview 11.3. North America Primary Cell Market Value Share Analysis, by Type 11.4. North America Primary Cell Market Forecast, by Type 11.4.1. Human Primary Cells 11.4.2. Animal Primary Cells 11.5. North America Primary Cell Market Value Share Analysis, by Origin 11.6. North America Primary Cell Market Forecast, by Origin 11.6.1. Hematopoietic Cells 11.6.2. Skin Cells 11.6.3. Gastrointestinal Cells 11.6.4. Liver Cells 11.6.5. Lung Cells 11.6.6. Renal Cells 11.6.7. Heart Cells 11.6.8. Skeletal & Muscle Cells 11.6.9. Other Primary Cells 11.7. North America Primary Cell Market Value Share Analysis, by End User 11.8. North America Primary Cell Market Forecast, by End User 11.8.1. Life Science Research Companies 11.8.2. Research Institutes 11.9. North America Primary Cell Market Value Share Analysis, by Country 11.10. North America Primary Cell Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Primary Cell Market Analysis, by Country 11.12. U.S. Primary Cell Market Forecast, by Type 11.12.1. Human Primary Cells 11.12.2. Animal Primary Cells 11.13. U.S. Primary Cell Market Forecast, by Origin 11.13.1. Hematopoietic Cells 11.13.2. Skin Cells 11.13.3. Gastrointestinal Cells 11.13.4. Liver Cells 11.13.5. Lung Cells 11.13.6. Renal Cells 11.13.7. Heart Cells 11.13.8. Skeletal & Muscle Cells 11.13.9. Other Primary Cells 11.14. U.S. Primary Cell Market Forecast, by End User 11.14.1. Life Science Research Companies 11.14.2. Research Institutes 11.15. Canada Primary Cell Market Forecast, by Type 11.15.1. Human Primary Cells 11.15.2. Animal Primary Cells 11.16. Steel Canada Primary Cell Market Forecast, by Origin 11.16.1. Hematopoietic Cells 11.16.2. Skin Cells 11.16.3. Gastrointestinal Cells 11.16.4. Liver Cells 11.16.5. Lung Cells 11.16.6. Renal Cells 11.16.7. Heart Cells 11.16.8. Skeletal & Muscle Cells 11.16.9. Other Primary Cells 11.17. Canada Primary Cell Market Forecast, by End User 11.17.1. Life Science Research Companies 11.17.2. Research Institutes 11.18. North America Primary Cell Market Attractiveness Analysis 11.18.1. By Type 11.18.2. By Origin 11.18.3. By End User 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Primary Cell Market Analysis 12.1. Key Findings 12.2. Europe Primary Cell Market Overview 12.3. Europe Primary Cell Market Value Share Analysis, by Type 12.4. Europe Primary Cell Market Forecast, by Type 12.4.1. Human Primary Cells 12.4.2. Animal Primary Cells 12.5. Europe Primary Cell Market Value Share Analysis, by Origin 12.6. Europe Primary Cell Market Forecast, by Origin 12.6.1. Hematopoietic Cells 12.6.2. Skin Cells 12.6.3. Gastrointestinal Cells 12.6.4. Liver Cells 12.6.5. Lung Cells 12.6.6. Renal Cells 12.6.7. Heart Cells 12.6.8. Skeletal & Muscle Cells 12.6.9. Other Primary Cells 12.7. Europe Primary Cell Market Value Share Analysis, by End User 12.8. Europe Primary Cell Market Forecast, by End User 12.8.1. Life Science Research Companies 12.8.2. Research Institutes 12.9. Europe Primary Cell Market Value Share Analysis, by Country 12.10. Europe Primary Cell Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Primary Cell Market Analysis, by Country 12.12. Germany Primary Cell Market Forecast, by Type 12.12.1. Human Primary Cells 12.12.2. Animal Primary Cells 12.13. Germany Primary Cell Market Forecast, by Origin 12.13.1. Hematopoietic Cells 12.13.2. Skin Cells 12.13.3. Gastrointestinal Cells 12.13.4. Liver Cells 12.13.5. Lung Cells 12.13.6. Renal Cells 12.13.7. Heart Cells 12.13.8. Skeletal & Muscle Cells 12.13.9. Other Primary Cells 12.14. Germany Primary Cell Market Forecast, by End User 12.14.1. Life Science Research Companies 12.14.2. Research Institutes 12.15. U.K. Primary Cell Market Forecast, by Type 12.15.1. Human Primary Cells 12.15.2. Animal Primary Cells 12.16. U.K. Primary Cell Market Forecast, by Origin 12.16.1. Hematopoietic Cells 12.16.2. Skin Cells 12.16.3. Gastrointestinal Cells 12.16.4. Liver Cells 12.16.5. Lung Cells 12.16.6. Renal Cells 12.16.7. Heart Cells 12.16.8. Skeletal & Muscle Cells 12.16.9. Other Primary Cells 12.17. U.K. Primary Cell Market Forecast, by End User 12.17.1. Life Science Research Companies 12.17.2. Research Institutes 12.18. France Primary Cell Market Forecast, by Type 12.18.1. Human Primary Cells 12.18.2. Animal Primary Cells 12.19. France Primary Cell Market Forecast, by Origin 12.19.1. Hematopoietic Cells 12.19.2. Skin Cells 12.19.3. Gastrointestinal Cells 12.19.4. Liver Cells 12.19.5. Lung Cells 12.19.6. Renal Cells 12.19.7. Heart Cells 12.19.8. Skeletal & Muscle Cells 12.19.9. Other Primary Cells 12.20. France Primary Cell Market Forecast, by End User 12.20.1. Life Science Research Companies 12.20.2. Research Institutes 12.21. Italy Primary Cell Market Forecast, by Type 12.21.1. Human Primary Cells 12.21.2. Animal Primary Cells 12.22. Italy Primary Cell Market Forecast, by Origin 12.22.1. Hematopoietic Cells 12.22.2. Skin Cells 12.22.3. Gastrointestinal Cells 12.22.4. Liver Cells 12.22.5. Lung Cells 12.22.6. Renal Cells 12.22.7. Heart Cells 12.22.8. Skeletal & Muscle Cells 12.22.9. Other Primary Cells 12.23. Italy Primary Cell Market Forecast, by End User 12.23.1. Life Science Research Companies 12.23.2. Research Institutes 12.24. Spain Primary Cell Market Forecast, by Type 12.24.1. Human Primary Cells 12.24.2. Animal Primary Cells 12.25. Spain Primary Cell Market Forecast, by Origin 12.25.1. Hematopoietic Cells 12.25.2. Skin Cells 12.25.3. Gastrointestinal Cells 12.25.4. Liver Cells 12.25.5. Lung Cells 12.25.6. Renal Cells 12.25.7. Heart Cells 12.25.8. Skeletal & Muscle Cells 12.26. Other Primary Cells Spain Primary Cell Market Forecast, by End User 12.26.1. Life Science Research Companies 12.26.2. Research Institutes 12.27. Rest of Europe Primary Cell Market Forecast, by Type 12.27.1. Human Primary Cells 12.27.2. Animal Primary Cells 12.28. Rest of Europe Primary Cell Market Forecast, by Origin 12.28.1. Hematopoietic Cells 12.28.2. Skin Cells 12.28.3. Gastrointestinal Cells 12.28.4. Liver Cells 12.28.5. Lung Cells 12.28.6. Renal Cells 12.28.7. Heart Cells 12.28.8. Skeletal & Muscle Cells 12.28.9. Other Primary Cells 12.29. Rest Of Europe Primary Cell Market Forecast, by End User 12.29.1. Life Science Research Companies 12.29.2. Research Institutes 12.30. Europe Primary Cell Market Attractiveness Analysis 12.30.1. By Type 12.30.2. By Origin 12.30.3. By End User 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Primary Cell Market Analysis 13.1. Key Findings 13.2. Asia Pacific Primary Cell Market Overview 13.3. Asia Pacific Primary Cell Market Value Share Analysis, by Type 13.4. Asia Pacific Primary Cell Market Forecast, by Type 13.4.1. Human Primary Cells 13.4.2. Animal Primary Cells 13.5. Asia Pacific Primary Cell Market Value Share Analysis, by Origin 13.6. Asia Pacific Primary Cell Market Forecast, by Origin 13.6.1. Hematopoietic Cells 13.6.2. Skin Cells 13.6.3. Gastrointestinal Cells 13.6.4. Liver Cells 13.6.5. Lung Cells 13.6.6. Renal Cells 13.6.7. Heart Cells 13.6.8. Skeletal & Muscle Cells 13.6.9. Other Primary Cells 13.7. Asia Pacific Primary Cell Market Value Share Analysis, by End User 13.8. Asia Pacific Primary Cell Market Forecast, by End User 13.8.1. Life Science Research Companies 13.8.2. Research Institutes 13.9. Asia Pacific Primary Cell Market Value Share Analysis, by Country 13.10. Asia Pacific Primary Cell Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Primary Cell Market Analysis, by Country 13.12. China Primary Cell Market Forecast, by Type 13.12.1. Human Primary Cells 13.12.2. Animal Primary Cells 13.13. China Primary Cell Market Forecast, by Origin 13.13.1. Hematopoietic Cells 13.13.2. Skin Cells 13.13.3. Gastrointestinal Cells 13.13.4. Liver Cells 13.13.5. Lung Cells 13.13.6. Renal Cells 13.13.7. Heart Cells 13.13.8. Skeletal & Muscle Cells 13.13.9. Other Primary Cells 13.14. China Primary Cell Market Forecast, by End User 13.14.1. Life Science Research Companies 13.14.2. Research Institutes 13.15. India Primary Cell Market Forecast, by Type 13.15.1. Human Primary Cells 13.15.2. Animal Primary Cells 13.16. India Primary Cell Market Forecast, by Origin 13.16.1. Hematopoietic Cells 13.16.2. Skin Cells 13.16.3. Gastrointestinal Cells 13.16.4. Liver Cells 13.16.5. Lung Cells 13.16.6. Renal Cells 13.16.7. Heart Cells 13.16.8. Skeletal & Muscle Cells 13.16.9. Other Primary Cells 13.17. India Primary Cell Market Forecast, by End User 13.17.1. Life Science Research Companies 13.17.2. Research Institutes 13.18. Japan Primary Cell Market Forecast, by Type 13.18.1. Human Primary Cells 13.18.2. Animal Primary Cells 13.19. Japan Primary Cell Market Forecast, by Origin 13.19.1. Hematopoietic Cells 13.19.2. Skin Cells 13.19.3. Gastrointestinal Cells 13.19.4. Liver Cells 13.19.5. Lung Cells 13.19.6. Renal Cells 13.19.7. Heart Cells 13.19.8. Skeletal & Muscle Cells 13.19.9. Other Primary Cells 13.20. Japan Primary Cell Market Forecast, by End User 13.20.1. Life Science Research Companies 13.20.2. Research Institutes 13.21. ASEAN Primary Cell Market Forecast, by Type 13.21.1. Human Primary Cells 13.21.2. Animal Primary Cells 13.22. ASEAN Primary Cell Market Forecast, by Origin 13.22.1. Hematopoietic Cells 13.22.2. Skin Cells 13.22.3. Gastrointestinal Cells 13.22.4. Liver Cells 13.22.5. Lung Cells 13.22.6. Renal Cells 13.22.7. Heart Cells 13.22.8. Skeletal & Muscle Cells 13.22.9. Other Primary Cells 13.23. ASEAN Primary Cell Market Forecast, by End User 13.23.1. Life Science Research Companies 13.23.2. Research Institutes 13.24. Rest of Asia Pacific Primary Cell Market Forecast, by Type 13.24.1. Human Primary Cells 13.24.2. Animal Primary Cells 13.25. Rest of Asia Pacific Primary Cell Market Forecast, by Origin 13.25.1. Hematopoietic Cells 13.25.2. Skin Cells 13.25.3. Gastrointestinal Cells 13.25.4. Liver Cells 13.25.5. Lung Cells 13.25.6. Renal Cells 13.25.7. Heart Cells 13.25.8. Skeletal & Muscle Cells 13.25.9. Other Primary Cells 13.26. Rest of Asia Pacific Primary Cell Market Forecast, by End User 13.26.1. Life Science Research Companies 13.26.2. Research Institutes 13.27. Asia Pacific Primary Cell Market Attractiveness Analysis 13.27.1. By Type 13.27.2. By Origin 13.27.3. By End User 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Primary Cell Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Primary Cell Market Overview 14.3. Middle East & Africa Primary Cell Market Value Share Analysis, by Type 14.4. Middle East & Africa Primary Cell Market Forecast, by Type 14.4.1. Human Primary Cells 14.4.2. Animal Primary Cells 14.5. Middle East & Africa Primary Cell Market Value Share Analysis, by Origin 14.6. Middle East & Africa Primary Cell Market Forecast, by Origin 14.6.1. Hematopoietic Cells 14.6.2. Skin Cells 14.6.3. Gastrointestinal Cells 14.6.4. Liver Cells 14.6.5. Lung Cells 14.6.6. Renal Cells 14.6.7. Heart Cells 14.6.8. Skeletal & Muscle Cells 14.6.9. Other Primary Cells 14.7. Middle East & Africa Primary Cell Market Value Share Analysis, by End User 14.8. Middle East & Africa Primary Cell Market Forecast, by End User 14.8.1. Life Science Research Companies 14.8.2. Research Institutes 14.9. Middle East & Africa Primary Cell Market Value Share Analysis, by Country 14.10. Middle East & Africa Primary Cell Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Primary Cell Market Analysis, by Country 14.12. GCC Primary Cell Market Forecast, by Type 14.12.1. Human Primary Cells 14.12.2. Animal Primary Cells 14.13. GCC Primary Cell Market Forecast, by Origin 14.13.1. Hematopoietic Cells 14.13.2. Skin Cells 14.13.3. Gastrointestinal Cells 14.13.4. Liver Cells 14.13.5. Lung Cells 14.13.6. Renal Cells 14.13.7. Heart Cells 14.13.8. Skeletal & Muscle Cells 14.13.9. Other Primary Cells 14.14. GCC Primary Cell Market Forecast, by End User 14.14.1. Life Science Research Companies 14.14.2. Research Institutes 14.15. South Africa Primary Cell Market Forecast, by Type 14.15.1. Human Primary Cells 14.15.2. Animal Primary Cells 14.16. South Africa Primary Cell Market Forecast, by Origin 14.16.1. Hematopoietic Cells 14.16.2. Skin Cells 14.16.3. Gastrointestinal Cells 14.16.4. Liver Cells 14.16.5. Lung Cells 14.16.6. Renal Cells 14.16.7. Heart Cells 14.16.8. Skeletal & Muscle Cells 14.16.9. Other Primary Cells 14.17. South Africa Primary Cell Market Forecast, by End User 14.17.1. Life Science Research Companies 14.17.2. Research Institutes 14.18. Rest of Middle East & Africa Primary Cell Market Forecast, by Type 14.18.1. Human Primary Cells 14.18.2. Animal Primary Cells 14.19. Rest of Middle East & Africa Primary Cell Market Forecast, by Origin 14.19.1. Hematopoietic Cells 14.19.2. Skin Cells 14.19.3. Gastrointestinal Cells 14.19.4. Liver Cells 14.19.5. Lung Cells 14.19.6. Renal Cells 14.19.7. Heart Cells 14.19.8. Skeletal & Muscle Cells 14.19.9. Other Primary Cells 14.20. Rest of Middle East & Africa Primary Cell Market Forecast, by End User 14.20.1. Life Science Research Companies 14.20.2. Research Institutes 14.21. Middle East & Africa Primary Cell Market Attractiveness Analysis 14.21.1. By Type 14.21.2. By Origin 14.21.3. By End User 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Primary Cell Market Analysis 15.1. Key Findings 15.2. South America Primary Cell Market Overview 15.3. South America Primary Cell Market Value Share Analysis, by Type 15.4. South America Primary Cell Market Forecast, by Type 15.4.1. Human Primary Cells 15.4.2. Animal Primary Cells 15.5. South America Primary Cell Market Value Share Analysis, by Origin 15.6. South America Primary Cell Market Forecast, by Origin 15.6.1. Hematopoietic Cells 15.6.2. Skin Cells 15.6.3. Gastrointestinal Cells 15.6.4. Liver Cells 15.6.5. Lung Cells 15.6.6. Renal Cells 15.6.7. Heart Cells 15.6.8. Skeletal & Muscle Cells 15.6.9. Other Primary Cells 15.7. South America Primary Cell Market Value Share Analysis, by End User 15.8. South America Primary Cell Market Forecast, by End User 15.8.1. Life Science Research Companies 15.8.2. Research Institutes 15.9. South America Primary Cell Market Value Share Analysis, by Country 15.10. South America Primary Cell Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Primary Cell Market Analysis, by Country 15.12. Brazil Primary Cell Market Forecast, by Type 15.12.1. Human Primary Cells 15.12.2. Animal Primary Cells 15.13. Brazil Primary Cell Market Forecast, by Origin 15.13.1. Hematopoietic Cells 15.13.2. Skin Cells 15.13.3. Gastrointestinal Cells 15.13.4. Liver Cells 15.13.5. Lung Cells 15.13.6. Renal Cells 15.13.7. Heart Cells 15.13.8. Skeletal & Muscle Cells 15.13.9. Other Primary Cells 15.14. Brazil Primary Cell Market Forecast, by End User 15.14.1. Life Science Research Companies 15.14.2. Research Institutes 15.15. Mexico Primary Cell Market Forecast, by Type 15.15.1. Human Primary Cells 15.15.2. Animal Primary Cells 15.16. Mexico Primary Cell Market Forecast, by Origin 15.16.1. Hematopoietic Cells 15.16.2. Skin Cells 15.16.3. Gastrointestinal Cells 15.16.4. Liver Cells 15.16.5. Lung Cells 15.16.6. Renal Cells 15.16.7. Heart Cells 15.16.8. Skeletal & Muscle Cells 15.16.9. Other Primary Cells 15.17. Mexico Primary Cell Market Forecast, by End User 15.17.1. Life Science Research Companies 15.17.2. Research Institutes 15.18. Rest of South America Primary Cell Market Forecast, by Type 15.18.1. Human Primary Cells 15.18.2. Animal Primary Cells 15.19. Rest of South America Primary Cell Market Forecast, by Origin 15.19.1. Hematopoietic Cells 15.19.2. Skin Cells 15.19.3. Gastrointestinal Cells 15.19.4. Liver Cells 15.19.5. Lung Cells 15.19.6. Renal Cells 15.19.7. Heart Cells 15.19.8. Skeletal & Muscle Cells 15.19.9. Other Primary Cells 15.20. Rest of South America Primary Cell Market Forecast, by End User 15.20.1. Life Science Research Companies 15.20.2. Research Institutes 15.21. South America Primary Cell Market Attractiveness Analysis 15.21.1. By Type 15.21.2. By Origin 15.21.3. By End User 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Cell Biologics 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. ZenBio, 16.3.3. Axol Biosciences 16.3.4. Thermo Fisher Scientific, 16.3.5. Merck KGaA 16.3.6. Lonza 16.3.7. American Type Culture Collection 16.3.8. Promocell 16.3.9. STEMCELL Technologies 16.3.10. PromoCell 16.3.11. KGaA 16.3.12. Duracell 16.3.13. Energizer 16.3.14. Hitachi Maxell 16.3.15. Sony 16.3.16. Toshiba 16.3.17. Saft 16.3.18. EXCELL Battery Group 16.3.19. Quallion 16.3.20. Panasonic 16.3.21. GP Batteries 16.3.22. Dongguan Large Electronics. 16.3.23. HemaCare Corporation 16.3.24. AllCells 17. Primary Key Insights